The world's scientific and social network for malaria professionals
Subscribe to free Newsletter | 10434 malaria professionals are enjoying the free benefits of MalariaWorld today

malaria

Plasmodium vivax

July 4, 2019 - 15:13 -- Open Access
Author(s): 
Erika L. Flannery, Miles B. Markus, and Ashley M. Vaughan
Reference: 
Trends in Parasitology, July 2019, 35, No. 7

Plasmodium vivax is the most widely distributed of several plasmodial species that cause human malaria, a disease associated with blood-stage parasite replication. About 2.5 billion people are at risk of P. vivax infection; they live mainly in Southeast Asia and the Americas, where P. vivax accounts for approximately 72% of malaria cases.

Medical Condition: 

New from MESA: MESA Correspondents bring you cutting-edge coverage from the 7th International Conference on Plasmodium vivax Research - Day 3

July 1, 2019 - 19:47 -- MESA Alliance

Day 3: Friday, 28th June

Wrapping up the 7th International Conference on Plasmodium vivax Research, day three focused on the topics of P. vivax drugs and approaches for P. vivax elimination.

New from MESA: MESA Correspondents bring you cutting-edge coverage from the 7th International Conference on Plasmodium vivax Research - Day 2

July 1, 2019 - 10:57 -- MESA Alliance

Day 2: Thursday, 27th June

The main focus of the presentations on day two of the 7th International Conference on Plasmodium vivax Research was on laboratory exploration of P. vivax biological characteristics, parasite development stages and host-parasite interaction. There was a lively poster session during the lunch period and a conference dinner at the magnificent Musée d’Orsay.

RBM Partnership To End Malaria Annual Report 2018

June 26, 2019 - 20:02 -- Malaria World

2018 was the first year of the RBM Partnership to End Malaria’s 2018–2020 Strategic Plan (see page 7), which aims to use the partnership to boost political commitment, regional cooperation and malaria financing. The Partnership, through consultations with partners and malaria-endemic countries, launched new initiatives in support of global efforts to end malaria. 

Download the RBM Partnership To End Malaria Annual Report 2018 here

WHO - The E-2020 initiative of 21 malaria-eliminating countries: 2019 progress report

June 20, 2019 - 20:08 -- Malaria World

Creating a malaria-free world is a bold and important public health and sustainable development goal. It is also the vision of the Global technical strategy for malaria 2016-2030, which calls for the elimination of malaria in at least 10 countries by the year 2020.

In 2016, WHO identified 21 countries, spanning 5 regions, that could defeat malaria by 2020, considering the likelihood of elimination across key criteria. All are united by one target: to achieve zero indigenous cases of malaria within the 2020 timeline. This report charts their progress.

Download the E-2020 initiative of 21 malaria-eliminating countries: 2019 progress report here

New from MESA: MESA Correspondents reporting from the 7th International Conference on Plasmodium vivax research

June 20, 2019 - 13:43 -- MESA Alliance

The MESA Correspondent volunteers report on the latest in malaria research from conferences around the world. The synopses are shared online, enabling people who could not attend the meeting to read about the latest advances. The MESA Correspondents Program is a collaboration between MESA and the conference organizers.

Indoor residual spraying for preventing malaria in communities using insecticide‐treated nets

June 17, 2019 - 15:38 -- Open Access
Author(s): 
Leslie Choi, Joseph Pryce, Paul Garner
Reference: 
Cochrane Database of Systematic Reviews 2019, Issue 5. Art. No.: CD012688

Two review authors independently assessed trials for eligibility, analyzed risk of bias, and extracted data. We used risk ratio (RR) and 95% confidence intervals (CI). We stratified by type of insecticide: ‘non‐pyrethroid‐like', as this could improve malaria control better than adding IRS insecticides that have the same way of working as the insecticide on ITNs (‘pyrethroid‐like'). We used subgroup analysis of ITN usage in the trials to explore heterogeneity. We assessed the certainty of evidence using the GRADE approach.

Medical Condition: 

Pages

Subscribe to RSS - malaria